Induction of prosurvival molecules by apoptotic stimuli: involvement of FOXO3a and ROS

Jun-Wei Liu1, Dhyan Chandra, Michael D Rudd

  • 1Department of Carcinogenesis, the University of Texas MD Anderson Cancer Center, Science Park-Research Division 1C, Smithville, TX 78957, USA.

Oncogene
|January 28, 2005
PubMed

Insights

Cancer cells resist apoptosis by upregulating prosurvival molecules like Bcl-2/Bcl-X(L) and superoxide dismutase (SOD). This survival mechanism, activated by reactive oxygen species (ROS) and transcription factor FOXO3a, hinders cancer therapeutics.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Cancer therapeutics often fail due to rapid development of resistance by cancer cells to proapoptotic effects.
  • The precise mechanisms underlying this resistance are not fully understood.
  • Identifying these mechanisms is crucial for developing more effective cancer treatments.

Purpose of the Study:

  • To investigate the rapid induction of prosurvival molecules in response to apoptotic stimuli.
  • To elucidate the role of transcription factor FOXO3a and reactive oxygen species (ROS) in this process.
  • To explore potential strategies for overcoming therapeutic resistance in cancer.

Main Methods:

  • Induction of apoptosis using serum starvation, a mitochondrial toxin, and etoposide.
  • Analysis of prosurvival (Bcl-2/Bcl-X(L), SOD) and proapoptotic (Bim, Bak) molecule expression.
  • Utilized siRNAs to block molecule induction and assess effects on apoptosis.
  • Investigated the role of transcription factor FOXO3a and ROS using inhibitors/scavengers.

Main Results:

  • Apoptotic stimuli rapidly induced prosurvival molecules (Bcl-2/Bcl-X(L), SOD) before or concurrently with proapoptotic molecules (Bim, Bak).
  • FOXO3a was identified as a master transcription factor involved in regulating both prosurvival and proapoptotic molecules, and was itself upregulated.
  • Reactive oxygen species (ROS) were rapidly induced and found to mediate the upregulation of FOXO3a, MnSOD, and Bim.
  • Prosurvival mechanisms were also activated in normal fibroblasts and at subapoptotic concentrations.

Conclusions:

  • Apoptotic stimuli rapidly activate prosurvival mechanisms via ROS-dependent pathways involving transcription factor FOXO3a.
  • Cancer cells and normal cells mobilize survival strategies in response to apoptotic triggers.
  • Effective anticancer therapeutics may require combined strategies targeting both apoptosis induction and survival suppression.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...